Shanghai Oripharm Co.ltd.

Country/Region: China     State/Province: Shanghai

Main Products: Coenzyme A

Company Introduction
Shanghai Oripharm Co.,Ltd. is a professional biochemicals manufacturer and supplier in China.It was established in 2003,and grows rapidly in the field of Nucleic Acid Biochemistry. Oripharm develop and commercialization many kinds of active substances, key intermediates and reagents which are being widely used in pharmaceuticals, diagnostics, cosmetics,molecular biology and food industry as well.Oripharm specialize in Nucleosides , Nucleotides and their analogues. We offer more than 250 products including various kinds of Ribonucleosides,Ribonucleotides,Deoxynucleosides, Deoxynucleotides, Arabinonucleosides,Carbohydrates,Coenzymes Cyclophosphates,Purines and Pyrimidines.All the products have been applied in the worldwide pharmaceutical company,biotechnology company, diagnostics company,cosmetics company and food company. Famous for its reliable quality products and excellent services,Oripharm enjoy a good popularity among our global customers in the past years and also establish a collaborative relationship with several famous multinational companies in the world.Oripharm's main strength is not only to supply high quality products to our customers but also continuously develop advanced technology and special items to meet our customers specific requirements. Oripharm dedicate itself not only to take lead in Nucleic Acid Biochemistry but also to develop win-win strategy with our global customers in the future.
Company Overview

Business Type: Manufacturer, Buying House

Year Established: 2003

Employees: 501 - 1000 People

Plant Area: Below 1,000 square meters

Contact Information

Fax: 0086-21-64814386

Business Information

Main Markets: South America 12% Africa 8% Eastern Asia 8% Domestic Market 8% North America 10% Eastern Europe 8% Southern Europe 11% Mid East 8% Northern Europe 10% Oceania 17%

Trade Capacity: FOB, CFR, DDP

Contract Manufacturing: OEM Service Offered,Buyer Label Offered

Nearest Port: Shanghai

Trade & Financial Information

Annual Revenue: Below US$1 Million

Total Revenue: Below US$1 Million

Export Revenue: US$2.5 Million - US$5 Million

Annual Output: US$5 Million - US$10 Million

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 1% - 10%

Payment Modes: USD, JPY, CHF

Lead Time: 25 days

Import/Export Mode: Have Own Export License

Product Showcase
coenzyme A

CL-Link > Health & Medicines in China Health & Medicines in Shanghai Medicines in China Medicines in Shanghai Cilnidipine in China Cilnidipine in Shanghai